Products
products details
Home > Products >
PAR1 Protease Activated Receptor 1 Antagonist Enzyme Inhibitor Peptides Catalog KS181024

PAR1 Protease Activated Receptor 1 Antagonist Enzyme Inhibitor Peptides Catalog KS181024

Product Details:
Catalog Number:
KS181024
Product Name:
Protease-Activated Receptor 1(PAR1) Antagonist
Sequence:
3Mercaptopropionyl-Fcha-Cha-RKPNDK-NH2
CAS NO.:
N/A
Price/1mg:
$28
Purity:
≥95% (HPLC)
Molecular Formula:
C54H89N17O15
Molecular Weight:
1216.4
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
High Light: 

Enzyme Inhibitor Peptides Antagonist

,

PAR1 Enzyme Inhibitor Peptides

,

Protease Activated Receptor 1 Antagonist

Product Description

Protease-Activated Receptor 1(PAR1) Antagonist,Lyophilized,Catalog Number:KS181024

 

Protease-activated receptor-1 (PAR 1) antagonists have an antiplatelet effect by inhibiting thrombin-related platelet aggregation. Thrombin's cellular effects are mediated by PARs therefore the action of the PAR 1 antagonists alters signaling in platelets and interferes with platelet activation.

Products
products details
Home > Products >
PAR1 Protease Activated Receptor 1 Antagonist Enzyme Inhibitor Peptides Catalog KS181024

PAR1 Protease Activated Receptor 1 Antagonist Enzyme Inhibitor Peptides Catalog KS181024

Product Details:
Catalog Number:
KS181024
Product Name:
Protease-Activated Receptor 1(PAR1) Antagonist
Sequence:
3Mercaptopropionyl-Fcha-Cha-RKPNDK-NH2
CAS NO.:
N/A
Price/1mg:
$28
Purity:
≥95% (HPLC)
Molecular Formula:
C54H89N17O15
Molecular Weight:
1216.4
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
Details Link:
Https://shopping.ks-vpeptide.com/sale-470683-par1-protease-activated-receptor-1-antagonist-enzyme-inhibitor-peptides-catalog-ks181024.htm
High Light: 

Enzyme Inhibitor Peptides Antagonist

,

PAR1 Enzyme Inhibitor Peptides

,

Protease Activated Receptor 1 Antagonist

Product Description

Protease-Activated Receptor 1(PAR1) Antagonist,Lyophilized,Catalog Number:KS181024

 

Protease-activated receptor-1 (PAR 1) antagonists have an antiplatelet effect by inhibiting thrombin-related platelet aggregation. Thrombin's cellular effects are mediated by PARs therefore the action of the PAR 1 antagonists alters signaling in platelets and interferes with platelet activation.